<code id='0B4E0E0822'></code><style id='0B4E0E0822'></style>
    • <acronym id='0B4E0E0822'></acronym>
      <center id='0B4E0E0822'><center id='0B4E0E0822'><tfoot id='0B4E0E0822'></tfoot></center><abbr id='0B4E0E0822'><dir id='0B4E0E0822'><tfoot id='0B4E0E0822'></tfoot><noframes id='0B4E0E0822'>

    • <optgroup id='0B4E0E0822'><strike id='0B4E0E0822'><sup id='0B4E0E0822'></sup></strike><code id='0B4E0E0822'></code></optgroup>
        1. <b id='0B4E0E0822'><label id='0B4E0E0822'><select id='0B4E0E0822'><dt id='0B4E0E0822'><span id='0B4E0E0822'></span></dt></select></label></b><u id='0B4E0E0822'></u>
          <i id='0B4E0E0822'><strike id='0B4E0E0822'><tt id='0B4E0E0822'><pre id='0B4E0E0822'></pre></tt></strike></i>

          explore

          explore

          author:Wikipedia    Page View:87358
          JUUL store sign -- health coverage from STAT
          Stephanie Keith/Getty Images

          Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

          Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

          advertisement

          It’s not clear how much the company ultimately spent on the partnerships.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          ActiGraph execs on goal of drug approvals with digital endpoints
          ActiGraph execs on goal of drug approvals with digital endpoints

          JeremeyWyattActiGraphAsdrugmakerswadeintousingdigitalhealthtechnologies,ActiGraphhasmadeitsmissionto

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Google and Epic fight stronger regulation of AI in health care

          AdobeBigbusinessespoisedtoprofitfromtheadvanceofartificialintelligenceinhealthcarearepushingbackagai